TY - JOUR
T1 - Geographical distribution, disease association and diversity of Klebsiella pneumoniae K/L and O antigens in India
T2 - roadmap for vaccine development
AU - NIHR Global Health Research Unit on genomic surveillance-India consortium
AU - Shamanna, Varun
AU - Srinivas, Srikanth
AU - Couto, Natacha
AU - Nagaraj, Geetha
AU - Sajankila, Shyama Prasad
AU - Krishnappa, Harshitha Gangaiah
AU - Kumar, Kavitha Arakalgud
AU - Aanensen, David M.
AU - Lingegowda, Ravikumar Kadahalli
AU - David, Sophia
AU - Abrudan, Monica
AU - Caballero, Julio Diaz
AU - Kumaran, Emmanuelle
AU - Lewis-Woodhouse, Georgina
AU - Abudahab, Khalil
AU - Pascoe, Ben
AU - Donado-Godoy, Pilar
AU - Shreedhanya, D. M.
AU - Shincy, M. R.
AU - Sravani, D.
AU - Ravishankar, K. N.
AU - Okeke, Iruka N.
AU - Oaikhena, Anderson O.
AU - Sia, Sonia
AU - Carlos, Celia
AU - Lagrada, Marietta L.
AU - Gayeta, June M.
AU - Stelling, John
AU - Vegvari, Carolin
AU - Ujwal, P.
AU - Vidya, S. M.
AU - Chethan, D. M.
AU - Sharma, Anuradha
AU - Ray, Ujjwayini
AU - Das, Manick
AU - Sahu, Maneesha
AU - Poojary, Aruna
AU - Lakshmi,
AU - Shwetha,
AU - Mandal, Shubranshu
AU - Frincy,
AU - Anitha,
AU - Gupta, Varsha
AU - Rai, Namrata
AU - Bhattacharyya,
AU - Naveena,
AU - Sujatha,
AU - Verma, Sheetal
AU - Baliga, Shrikala
AU - Lakshmi,
N1 - Publisher Copyright:
© 2024 The Authors.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - Klebsiella pneumoniae poses a significant healthcare challenge due to its multidrug resistance and diverse serotype landscape. This study aimed to explore the serotype diversity of 1072 K. pneumoniae and its association with geographical distribution, disease severity and antimicrobial/virulence patterns in India. Whole-genome sequencing was performed on the Illumina plat-form, and genomic analysis was carried out using the Kleborate tool. The analysis revealed a total of 78 different KL types, among which KL64 (n=274/1072, 26 %), KL51 (n=249/1072, 24 %), and KL2 (n=88/1072, 8 %) were the most prevalent. In contrast, only 13 distinct O types were identified, with O1/O2v1 (n=471/1072, 44 %), O1/O2v2 (n=353/1072, 33 %), and OL101 (n=66/1072, 6 %) being the predominant serotypes. The study identified 114 different sequence types (STs) with varying serotypes, with ST231 being the most predominant. O serotypes were strongly linked with STs, with O1/O2v1 predominantly associated with ST231. Simpson’s diversity index and Fisher’s exact test revealed higher serotype diversity in the north and east regions, along with intriguing associations between specific serotypes and resistance profiles. No significant association between KL or O types and disease severity was observed. Furthermore, we found the specific association of virulence factors yersiniabactin and aerobactin (P<0.05) with KL types but no association with O antigen types (P>0.05). Conventionally described hypervirulent clones (i.e. KL1 and KL2) in India lacked typical virulent markers (i.e. aerobactin), contrasting with other regional serotypes (KL51). The cumulative distribution of KL and O serotypes suggests that future vaccines may have to include either ~20 KL or four O types to cover >85 % of the carbapenemase-producing Indian K. pneumoniae population. The results highlight the neces-sity for comprehensive strategies to manage the diverse landscape of K. pneumoniae strains across different regions in India. Understanding regional serotype dynamics is pivotal for targeted surveillance, interventions, and tailored vaccine strategies to tackle the diverse landscape of K. pneumoniae infections across India. This article contains data hosted by Microreact.
AB - Klebsiella pneumoniae poses a significant healthcare challenge due to its multidrug resistance and diverse serotype landscape. This study aimed to explore the serotype diversity of 1072 K. pneumoniae and its association with geographical distribution, disease severity and antimicrobial/virulence patterns in India. Whole-genome sequencing was performed on the Illumina plat-form, and genomic analysis was carried out using the Kleborate tool. The analysis revealed a total of 78 different KL types, among which KL64 (n=274/1072, 26 %), KL51 (n=249/1072, 24 %), and KL2 (n=88/1072, 8 %) were the most prevalent. In contrast, only 13 distinct O types were identified, with O1/O2v1 (n=471/1072, 44 %), O1/O2v2 (n=353/1072, 33 %), and OL101 (n=66/1072, 6 %) being the predominant serotypes. The study identified 114 different sequence types (STs) with varying serotypes, with ST231 being the most predominant. O serotypes were strongly linked with STs, with O1/O2v1 predominantly associated with ST231. Simpson’s diversity index and Fisher’s exact test revealed higher serotype diversity in the north and east regions, along with intriguing associations between specific serotypes and resistance profiles. No significant association between KL or O types and disease severity was observed. Furthermore, we found the specific association of virulence factors yersiniabactin and aerobactin (P<0.05) with KL types but no association with O antigen types (P>0.05). Conventionally described hypervirulent clones (i.e. KL1 and KL2) in India lacked typical virulent markers (i.e. aerobactin), contrasting with other regional serotypes (KL51). The cumulative distribution of KL and O serotypes suggests that future vaccines may have to include either ~20 KL or four O types to cover >85 % of the carbapenemase-producing Indian K. pneumoniae population. The results highlight the neces-sity for comprehensive strategies to manage the diverse landscape of K. pneumoniae strains across different regions in India. Understanding regional serotype dynamics is pivotal for targeted surveillance, interventions, and tailored vaccine strategies to tackle the diverse landscape of K. pneumoniae infections across India. This article contains data hosted by Microreact.
UR - https://www.scopus.com/pages/publications/85199383823
UR - https://www.scopus.com/pages/publications/85199383823#tab=citedBy
U2 - 10.1099/mgen.0.001271
DO - 10.1099/mgen.0.001271
M3 - Article
C2 - 39037209
AN - SCOPUS:85199383823
SN - 2057-5858
VL - 10
JO - Microbial Genomics
JF - Microbial Genomics
IS - 7
M1 - 001271
ER -